Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vlassara

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Molecular Medicine (Cambridge, Mass.)|March 26, 1998
Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasisJ J Li, D Dickson, P R Hof, et al.
Journal of Immunological Methods|August 22, 1997
Standardizing the immunological measurement of advanced glycation endproducts using normal human serumT Mitsuhashi, H Vlassara, H W Founds, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1993
Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patientsS M Korbet, Z Makita, C A Firanek, et al.
The Journal of Experimental Medicine|October 1, 1989
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant propertiesC Esposito, H Gerlach, J Brett, et al.
The Journal of Experimental Medicine|January 1, 1987
Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproductsD M Mosser, H Vlassara, P J Edelson, et al.
Kidney International. Supplement|June 1, 1995
Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosisC W Yang, H Vlassara, G E Striker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complicationsH Vlassara, H Fuh, Z Makita, et al.
The Journal of Experimental Medicine|August 1, 1987
Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cellsH Vlassara, J Valinsky, M Brownlee, et al.
Kidney International|January 4, 1998
Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremiaS Fishbane, R Bucala, B J Pereira, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
The role of advanced glycosylation end-products in the pathogenesis of atherosclerosisZ Makita, K Yanagisawa, S Kuwajima, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Molecular Medicine (Cambridge, Mass.)|March 26, 1998
Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasisJ J Li, D Dickson, P R Hof, et al.
Journal of Immunological Methods|August 22, 1997
Standardizing the immunological measurement of advanced glycation endproducts using normal human serumT Mitsuhashi, H Vlassara, H W Founds, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1993
Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patientsS M Korbet, Z Makita, C A Firanek, et al.
The Journal of Experimental Medicine|October 1, 1989
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant propertiesC Esposito, H Gerlach, J Brett, et al.
The Journal of Experimental Medicine|January 1, 1987
Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproductsD M Mosser, H Vlassara, P J Edelson, et al.
Kidney International. Supplement|June 1, 1995
Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosisC W Yang, H Vlassara, G E Striker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complicationsH Vlassara, H Fuh, Z Makita, et al.
The Journal of Experimental Medicine|August 1, 1987
Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cellsH Vlassara, J Valinsky, M Brownlee, et al.
Kidney International|January 4, 1998
Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremiaS Fishbane, R Bucala, B J Pereira, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
The role of advanced glycosylation end-products in the pathogenesis of atherosclerosisZ Makita, K Yanagisawa, S Kuwajima, et al.
Pageof 12